Suppr超能文献

口服米索前列醇引产:一项回顾性队列研究。

Labor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Study.

机构信息

Department of Clinical Science and Education, Karolinska Institutet, Women's Clinic, Sodersjukhuset, Sweden.

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

出版信息

Biomed Res Int. 2017;2017:6840592. doi: 10.1155/2017/6840592. Epub 2017 Sep 18.

Abstract

INTRODUCTION

One great challenge in obstetric care is labor inductions. Misoprostol has advantages in being cheap and stable at room temperature and available in resource-poor settings.

MATERIAL AND METHODS

Retrospective cohort study of 4002 singleton pregnancies with a gestational age ≥34 w at Sodersjukhuset, Stockholm, during 2009-2010 and 2012-2013. Previously used methods of labor induction were compared with misoprostol given as a solution to drink, every second hour. Main outcome is as follows: Cesarean Section (CS) rate, acid-base status in cord blood, Apgar score < 7,5', active time of labor, and blood loss > 1500 ml (PPH).

RESULTS

The proportion of CS decreased from 26% to 17% when orally given solution of misoprostol was introduced at the clinic ( < 0.001). No significant difference in the frequency of low Apgar score ( = 0.3), low aPh in cord blood ( = 0.1), or PPH ( = 0.4) between the different methods of induction was studied. After adjustment for different risk factor for CS the only method of induction which was associated with CS was dinoproston (Propess®) (aor = 2.9 (1.6-5.2)).

CONCLUSION

Induction of labor with misoprostol, given as an oral solution to drink every second hour, gives a low rate of CS, without affecting maternal or fetal outcome.

摘要

引言

产科护理的一大挑战是引产。米索前列醇具有价格低廉、在室温下稳定且在资源匮乏的环境中可获得的优势。

材料和方法

这是一项在斯德哥尔摩 Sodersjukhuset 进行的回顾性队列研究,纳入了 2009-2010 年和 2012-2013 年期间 4002 例胎龄≥34 周的单胎妊娠。比较了之前使用的引产方法与每两小时口服米索前列醇溶液的方法。主要结局如下:剖宫产率、脐带血酸碱状态、Apgar 评分<7.5、产程活跃时间和出血量>1500ml(产后出血)。

结果

当在诊所引入口服米索前列醇溶液时,剖宫产率从 26%降至 17%(<0.001)。不同引产方法之间的 Apgar 评分低(=0.3)、脐带血 aPh 低(=0.1)或产后出血(=0.4)的发生率无显著差异。在调整了剖宫产的不同危险因素后,唯一与剖宫产相关的引产方法是地诺前列酮(Propess®)(aOR=2.9(1.6-5.2))。

结论

口服米索前列醇溶液每两小时一次引产可降低剖宫产率,且不影响母婴结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334b/5624161/0b69313e1322/BMRI2017-6840592.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验